Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on ...
Cervical cancer is the fourth most common cancer in women but is largely preventable through HPV vaccination and regular screening. 1 Evidence shows that organized screening and early detection ...
Aptima Assay was approved for use when Pap smear finds cells of undetermined significance and as an adjunct to Pap testing. FDA approved Gen-Probe’s Aptima HPV assay for use on the firm’s automated ...
Hologic announced that the FDA has approved the Aptima HPV 16 18/45 Genotype Assay for genotyping human papillomavirus (HPV) types 16, 18 and/or 45 on its Tigris instrument system. Hologic’s Aptima ...
BEDFORD, Mass., April 4, 2013 /CNW/ - Hologic, Inc. announced today that Health Canada has granted medical device licenses for Hologic's APTIMA HPV and APTIMA HPV 16 18/45 genotype assays. Both assays ...
FDA approved Hologic’s Aptima HPV 16 18/45 Genotype Assay for use on the firm’s Tigris system. Hologic says the assay is the first cleared in the U.S. for genotyping human papilloma virus (HPV) types ...
Gen-Probe Incorporated has that the Company has launched in Europe its APTIMA® HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HPV), ...
Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the ...
The US Food and Drug Administration (FDA) has approved Hologic, Inc.'s Aptima HPV 16 18/45 genotype assay for use on the company's fully automated Panther system. The Aptima HPV 16 18/45 genotype ...
BEDFORD, Mass., Nov. 7, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) , a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and ...
The addition of the Hologic Aptima HPV 16 18/45 genotype assay completes the HPV portfolio on the popular and fully automated laboratory system BEDFORD, Mass., Feb. 4, 2014 /CNW/ - Hologic, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results